497 related articles for article (PubMed ID: 17156207)
1. Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat.
Holland PR; Akerman S; Goadsby PJ
Eur J Neurosci; 2006 Nov; 24(10):2825-33. PubMed ID: 17156207
[TBL] [Abstract][Full Text] [Related]
2. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.
Holland PR; Akerman S; Goadsby PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1380-5. PubMed ID: 16160082
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nociceptive dural input in the trigeminal nucleus caudalis by somatostatin receptor blockade in the posterior hypothalamus.
Bartsch T; Levy MJ; Knight YE; Goadsby PJ
Pain; 2005 Sep; 117(1-2):30-9. PubMed ID: 16043293
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area.
Bartsch T; Levy MJ; Knight YE; Goadsby PJ
Pain; 2004 Jun; 109(3):367-378. PubMed ID: 15157698
[TBL] [Abstract][Full Text] [Related]
5. Orexin-2 receptors inhibit primary afferent fiber-evoked responses of ventral roots in the neonatal rat isolated spinal cord.
Shono K; Yamamoto T
Brain Res; 2008 Jul; 1218():97-102. PubMed ID: 18511021
[TBL] [Abstract][Full Text] [Related]
6. Properties of neurons in the trigeminal nucleus caudalis responding to noxious dural and facial stimulation.
Bolton S; O'Shaughnessy CT; Goadsby PJ
Brain Res; 2005 Jun; 1046(1-2):122-9. PubMed ID: 15885666
[TBL] [Abstract][Full Text] [Related]
7. Role of orexin receptors in the nucleus accumbens in dopamine-dependent turning behaviour of rats.
Kotani A; Ikeda H; Koshikawa N; Cools AR
Neuropharmacology; 2008 Mar; 54(3):613-9. PubMed ID: 18160080
[TBL] [Abstract][Full Text] [Related]
8. Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferents.
Akerman S; Holland PR; Lasalandra MP; Goadsby PJ
Headache; 2009 Sep; 49(8):1131-43. PubMed ID: 19719541
[TBL] [Abstract][Full Text] [Related]
9. Role of dorsal vagal motor nucleus orexin-receptor-1 in glycemic responses to acute versus repeated insulin administration.
Paranjape S; Vavaiya K; Kale A; Briski K
Neuropeptides; 2007 Apr; 41(2):111-6. PubMed ID: 17276508
[TBL] [Abstract][Full Text] [Related]
10. Role of the ventromedial hypothalamic orexin-1 receptors in regulation of gastric Acid secretion in conscious rats.
Eliassi A; Nazari M; Naghdi N
J Neuroendocrinol; 2009 Mar; 21(3):177-82. PubMed ID: 19207823
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide and GABA mediate bi-directional cardiovascular effects of orexin in the nucleus tractus solitarii of rats.
Shih CD; Chuang YC
Neuroscience; 2007 Nov; 149(3):625-35. PubMed ID: 17916408
[TBL] [Abstract][Full Text] [Related]
12. Spinal orexin-1 receptors mediate anti-hyperalgesic effects of intrathecally-administered orexins in diabetic neuropathic pain model rats.
Kajiyama S; Kawamoto M; Shiraishi S; Gaus S; Matsunaga A; Suyama H; Yuge O
Brain Res; 2005 May; 1044(1):76-86. PubMed ID: 15862792
[TBL] [Abstract][Full Text] [Related]
13. Orexin A modulates neuronal activity of the rodent suprachiasmatic nucleus in vitro.
Klisch C; Inyushkin A; Mordel J; Karnas D; Pévet P; Meissl H
Eur J Neurosci; 2009 Jul; 30(1):65-75. PubMed ID: 19519637
[TBL] [Abstract][Full Text] [Related]
14. Orexin peptides enhance median preoptic nucleus neuronal excitability via postsynaptic membrane depolarization and enhancement of glutamatergic afferents.
Kolaj M; Coderre E; Renaud LP
Neuroscience; 2008 Sep; 155(4):1212-20. PubMed ID: 18674591
[TBL] [Abstract][Full Text] [Related]
15. The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy.
Rasmussen K; Hsu MA; Yang Y
Neuropsychopharmacology; 2007 Apr; 32(4):786-92. PubMed ID: 17063151
[TBL] [Abstract][Full Text] [Related]
16. The selective orexin 1 receptor antagonist SB-334867-A impairs acquisition and consolidation but not retrieval of spatial memory in Morris water maze.
Akbari E; Naghdi N; Motamedi F
Peptides; 2007 Mar; 28(3):650-6. PubMed ID: 17161886
[TBL] [Abstract][Full Text] [Related]
17. The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization.
Quarta D; Valerio E; Hutcheson DM; Hedou G; Heidbreder C
Neurochem Int; 2010 Jan; 56(1):11-5. PubMed ID: 19737591
[TBL] [Abstract][Full Text] [Related]
18. Orexin A decreases ketamine-induced anesthesia time in the rat: the relevance to brain noradrenergic neuronal activity.
Tose R; Kushikata T; Yoshida H; Kudo M; Furukawa K; Ueno S; Hirota K
Anesth Analg; 2009 Feb; 108(2):491-5. PubMed ID: 19151277
[TBL] [Abstract][Full Text] [Related]
19. Role of the orexinergic system in acute haemorrhage in the rat.
Hirota K; Kushikata T; Yoshida H; Kudo M; Kudo T
Neurosci Lett; 2008 Feb; 432(2):162-6. PubMed ID: 18187260
[TBL] [Abstract][Full Text] [Related]
20. Physiological regulation and NO-dependent inhibition of migrating myoelectric complex in the rat small bowel by OXA.
Ehrström M; Näslund E; Ma J; Kirchgessner AL; Hellström PM
Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G688-95. PubMed ID: 12816759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
